medigraphic.com

2008, Number 2

<< Back Next >>

Bioquimia 2008; 33 (2)

Biosafety in the laboratory: Important measures for safe work practices

Lara-Villegas HH, Ayala-Núñez NV, Rodríguez-Padilla C

Language: Spanish
References: 34
Page: 59-70
PDF size: 176.10 Kb.


ABSTRACT

A professional working in a clinical analysis, diagnosis, or pathology laboratory is frequently exposed to the risk of being infected with the pathogens being handled. The biosafety measures that must be taken into consideration when working inside the laboratory have already been established by national and international organizations, and they must be complied with fulfillment. In spite of this, there are certain cases in which one is not completely familiar with the level of risk, the kind of pathogen that is being handled, the measures to prevent an infection, the security levels of work, the basic personal protection equipment, and the way in which waste must be handled. Therefore, the main objective in the following text is to give a general overview of the biosafety measures to be taken in a laboratory that handles biological-infectious material.


REFERENCES

  1. Madigan MT, Martinko JM, Parker JB. Biología de los microorganismos. 8a ed. Madrid: Prentice Hall Iberia; 1999: p. 15-29.

  2. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health. Biosafety in microbiological and biomedical laboratories. 5a ed. Washington: Oficina de Imprenta del Gobierno de los Estados Unidos; 2007. p. 1-113.

  3. University of California, Irving. UCI Biosafety handbook. Rev. 2005. [Consultada en agosto 2007] Disponible en: http://www.ehs.uci.edu/programs/biosafety/bioSafety_handBook/index.html

  4. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupational acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol. 2003; 24: 86-96.

  5. Petrosillo N, Puro V, De Carli G, Ippolito G. Risks faced by laboratory workers in the AIDS era. J Biol Regul Homeost Agents. 2001; 15: 243-8.

  6. Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976; 13(2): 105-14.

  7. Herman P. Laboratory-acquired Infections: Introduction. Belgian biosafety server. 2007. [Consultada en septiembre 2007] Disponible en: http://www.biosecurite.be/CU/LAI/Intro_LAI.html

  8. Sewell DL. Laboratory-associated infections and biosafety. Clin Micro Rev. 1995; 8: 389-405.

  9. Health and Safety Office, University of North Carolina at Chapel Hill. Biological safety manual. 2000. [Consultada en septiembre 2007] Disponible en: http://ehs.unc.edu/manuals/bsm/

  10. Barkley WE. Risk assessment and containment. Howard Hughes Medical Institute. 2004. [Consultada en agosto 2007] Disponible en: http://www.webconferences.com/nihoba/ppt/Risk%20Assessment%2009-21-04_Barkley.pdf.

  11. Bavoil PM. Federal indifference to laboratory-acquired infections. Appl Biosafety. 2005; 3: 105-7.

  12. Lewis FM, Chernak E, Goldman E, Li Y, Karem K, Damon IK, et al. Ocular vaccinia infection in laboratory worker, Philadelphia 2004. Emerg Infect Dis. 2006; 12: 134-7.

  13. Wagenvoort JH, De Brauwer EI, Gronenschild JM, Toenbreker HM, Bonnemayers GP, Bilkert-Mooiman MA. Laboratory-acquired meticillin-resistant Staphylococcus aureus (MRSA) in two microbiology laboratory technicians. Eur J Clin Microbiol Infect Dis. 2006; 25: 470-2.

  14. Centers for Disease Control and Prevention. Salmonella serotype enteritidis infections among workers producing poultry vaccine, Maine. November - December 2006. Morbidity and mortality weekly report, Centers for Disease Control and Prevention. 2007; 56; 877-9.

  15. Minister of Health Population y Public Health Branch Centre for Emergency Preparedness and Response from Canada. The laboratory biosafety guidelines. 3a ed. 2004. [Consultada en agosto 2007] Disponible en: http://www.phac-aspc.gc.ca/ols-bsl/lbg-ldmbl/index.html

  16. Organización Mundial de la Salud. Laboratory biosafety manual. 3a ed. Génova: Organización Mundial de la Salud; 2004.

  17. Liberman DF, Harding LA. Biosafety: the research/diagnostic laboratory perspective. En: Liberman DF, editor. Biohazards management handbook. 2a. ed. Estados Unidos: Marcel Dekker; 1995. p. 151-71.

  18. Flanders Interuniversity Institute for Biotechnology. Biosafety in the laboratory. VIB publication. Bélgica: Flanders Interuniversity Institute for Biotechnology; 2004. p. 9-13.

  19. Mesa G, Rodríguez I, Teja J. Las enfermedades emergentes y reemergentes: un problema de salud en las Américas. Rev Panam Salud Publ. 2004; 15; 285-7.

  20. Organización Mundial de la Salud. Revisión del Reglamento Sanitario Internacional. 2005. [Consultada en agosto 2007] Disponible en: http://www.who.int/gb/ebwha/pdf_files/WHA 58/WHA58_3-sp.pdf

  21. Occupational Safety and Health Administration. Bloodborne pathogens.- 1910.1030. [Consultada en septiembre 2007] Disponible en: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051

  22. US Environmental Protection Agency. Selected EPA-registered disinfectants. [Consultada en octubre 2007] Disponible en: http://www.epa.gov/oppad001/chemregindex.htm

  23. Centers for Disease Control and Prevention. Universal precautions for prevention of transmission of HIV and other bloodborne infections. 1996. [Consultada en agosto 2007] Disponible en: http://www.cdc.gov/ncidod/dhqp/bp_universal_precautions.html

  24. Occupational Health Service, Queen Mary University of London. Universal precautions. [Consultada en agosto 2007] Disponible en: http://www.ohs.qmul.ac.uk/Universal %20Precautions.htm

  25. UK Health Departments. Guidance for Clinical Health Care Workers: Protection against infection with blood-borne viruses. [Consultada en agosto 2007] Disponible en: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014474.pdf

  26. Tashima K, Weiss M. Prevention of HIV transmission after health care worker occupational exposure. Med Health R I. 2003; 86: 172-4.

  27. Pruess A, Giroult E, Rushbrook P. Safe management of wastes from health-care activities. Ginebra, Suiza: Organización Mundial de la Salud; 1999.

  28. Norma Oficial Mexicana. NOM-087-ECOL-SSA1-2002. Protección ambiental - Salud ambiental - Residuos peligrosos biológico infecciosos - Clasificación y especificaciones de manejo. Diario Oficial de la Federación, 17 de febrero de 2003.

  29. Organización Mundial de la Salud. Wastes from health-care activities. Fact sheet No. 253. October 2000. [Consultada en agosto 2007] Disponible en: http://www.who.int/mediacentre/factsheets/fs253/en/

  30. Ley General de Salud. Diario Oficial de la Federación, 7 de febrero de 1984.

  31. Comisión Federal para la Protección contra Riesgos Sanitarios. Marco jurídico. [Consultada en agosto 2007] Disponible en: http://www.cofepris.gob.mx/mj/mj.htm

  32. Norma Oficial Mexicana. NOM-166-SSA1-1997. Para la organización y funcionamiento de los laboratorios clínicos. Diario Oficial de la Federación, 4 de diciembre de 1998.

  33. Norma Oficial Mexicana. NOM-003-SSA2-1993. Para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación, 8 de diciembre de 1993.

  34. Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. Diario Oficial de la Federación, 6 de enero de 1987.




2020     |     www.medigraphic.com